Literature DB >> 25928161

Tailored eHealth Lifestyle Promotion: Which Behavioral Modules Do Users Prefer?

Daniela N Schulz1, Stef P J Kremers, Hein De Vries.   

Abstract

Health risk behaviors are widespread among adults and often co-occur. eHealth computer-tailored technology provides individuals with personalized feedback regarding multiple lifestyle behaviors. First, the authors investigated individuals' preferences for particular lifestyle modules and hypothesised that health preventive behavior modules would be preferred over addictive behavior modules. Second, characteristics associated with these choices were examined. A web-based questionnaire assessed demographics, health status, and five lifestyle behaviors (i.e., physical activity, fruit consumption, vegetable consumption, alcohol intake and tobacco use) among adults (N = 1,828). Responses were translated into a health risk appraisal outlining whether respondents adhered to the national guidelines for these behaviors. Next, respondents could select one of the lifestyle modules providing personalized advice. More than 60% of the participants failed to meet the guidelines for more than one lifestyle behavior. The physical activity module was the most popular, followed by the smoking and fruit modules. Young adults tended to prefer the physical activity and fruit modules, whereas the vegetable module was more popular among older adults. No consistent pattern was identified for the alcohol and smoking modules. The results support the authors' hypothesis that health preventive behaviors-in particular, physical activity-would be preferred. Although this could imply that physical activity could serve as a gateway behavior when aiming at multiple behavior changes, it is also conceivable that other mechanisms, such as the actual success of behavior change, or the fact that people can choose, may increase chances of multiple behavior change. Hence, mechanisms leading to multiple behavior change need to be further explored.

Entities:  

Mesh:

Year:  2015        PMID: 25928161     DOI: 10.1080/10810730.2015.1012243

Source DB:  PubMed          Journal:  J Health Commun        ISSN: 1081-0730


  5 in total

1.  Process evaluation of TXT2BFiT: a multi-component mHealth randomised controlled trial to prevent weight gain in young adults.

Authors:  Stephanie R Partridge; Margaret Allman-Farinelli; Kevin McGeechan; Kate Balestracci; Annette T Y Wong; Lana Hebden; Mark F Harris; Adrian Bauman; Philayrath Phongsavan
Journal:  Int J Behav Nutr Phys Act       Date:  2016-01-19       Impact factor: 6.457

2.  Pilot Randomised Controlled Trial of a Web-Based Intervention to Promote Healthy Eating, Physical Activity and Meaningful Social Connections Compared with Usual Care Control in People of Retirement Age Recruited from Workplaces.

Authors:  Jose Lara; Nicola O'Brien; Alan Godfrey; Ben Heaven; Elizabeth H Evans; Scott Lloyd; Suzanne Moffatt; Paula J Moynihan; Thomas D Meyer; Lynn Rochester; Falko F Sniehotta; Martin White; John C Mathers
Journal:  PLoS One       Date:  2016-07-29       Impact factor: 3.240

3.  Web-Based Intervention for Physical Activity and Fruit and Vegetable Intake Among Chinese University Students: A Randomized Controlled Trial.

Authors:  Yan Ping Duan; Julian Wienert; Chun Hu; Gang Yan Si; Sonia Lippke
Journal:  J Med Internet Res       Date:  2017-04-10       Impact factor: 5.428

4.  Predictors of Self-Determined Module Choice in a Web-Based Computer-Tailored Diet and Physical Activity Intervention: Secondary Analysis of Data From a Randomized Controlled Trial.

Authors:  Juul M J Coumans; Catherine A W Bolman; Anke Oenema; Lilian Lechner
Journal:  J Med Internet Res       Date:  2020-07-23       Impact factor: 5.428

5.  Evaluation of a Web-Based Intervention for Multiple Health Behavior Changes in Patients With Coronary Heart Disease in Home-Based Rehabilitation: Pilot Randomized Controlled Trial.

Authors:  Yan Ping Duan; Wei Liang; Lan Guo; Julian Wienert; Gang Yan Si; Sonia Lippke
Journal:  J Med Internet Res       Date:  2018-11-19       Impact factor: 5.428

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.